Structurally Tractable Uncertain Data

Many data management applications must deal with data which is uncertain, incomplete, or noisy. However, on existing uncertain data representations, we cannot tractably perform the important query evaluation tasks of determining query possibility, certainty, or probability: these problems are hard on arbitrary uncertain input instances. We thus ask whether we could restrict the structure of uncertain data so as to guarantee the tractability of exact query evaluation. We present our tractability results for tree and tree-like uncertain data, and a vision for probabilistic rule reasoning. We also study uncertainty about order, proposing a suitable representation, and study uncertain data conditioned by additional observations.Comment: 11 pages, 1 figure, 1 table. To appear in SIGMOD/PODS PhD Symposium 201

The importance of therapeutic window in minimally invasive treatment of acute pancreatitis

Clinica Chirurgie II, Departamentul de Imagistică Medicală, Clinica Gastroenterologie, Clinica ATI I, Spitalul Clinic de Urgență, Sibiu, Al XI-lea Congres al Asociației Chirurgilor „Nicolae Anestiadi” din Republica Moldova și cea de-a XXXIII-a Reuniune a Chirurgilor din Moldova „Iacomi-Răzeșu” 27-30 septembrie 2011Introducere: Pancreatita acută este o afecțiune gravă cu o mortalitate ridicată în formele necrotico-hemoragice, în ciuda progreselor terapeutice actuale. Dorim să subliniem importanța instituirii terapiei corespunzătoare în intervalul „ferestrei terapeutice”, interval în care lanțul patogenic poate fi întrerupt (manevre miniinvazive). Material şi metodă: În 2006, în Clinica Chirurgie 2 a fost instituit un protocol terapeutic cu viza patogenică, ce asociază terapia medicală cu cea chirurgicală laparoscopică de decompresie precoce a arborelui biliopancreatic şi/sau necrectomie laparoscopică, în funcție de tipul pancreatitei acute. Alegerea momentului operator trebuie să fie precoce (fereastra terapeutică), bine documentată şi adaptată fiecărui caz în parte. Rezultate: Eficiența acestui protocol este obiectivată de reducerea la jumătate a incidenței formelor de pancreatită acută gravă precum şi de reducerea drastică a mortalității. Concluzii: Evoluția favorabilă a cazurilor tratate conform acestui protocol mixt, precum şi perioada de spitalizare relativ redusă, variind între un minim de 7 zile şi un maxim de 25 de zile, pledează pentru acest concept terapeutic patogenic, miniinvaziv.Introduction: Acute pancreatitis is a very serious disease with a high mortality in necrotic forms, despite the progresses made in therapeutic management. Our purpose is to underline the importance of establishing the suitable therapy within the interval of „therapeutic window”, when the pathogenic chain can be cutted down (minimally invasive maneuvers). Matherial and method: In 2006, in Clinic Surgery 2 it had beed established a protocol with pathogenic target which associates medical treatment and laparoscopic decompression of billiary tract and/or laparoscopic necrectomy adapted to the type of the pancreatitis. Chosing the operation moment must be precocious (within therapeutic window) well documented and adapted to each case separately. Results: The efficiency of this protocol is objectifiing through the reduction to half of the incidence of the severe forms of acute pancreatitis and also drastically redu ction of the mortality. Conclusions: The favourable evolution of the cases treated according to this mixt protocol and the relative short period of spitalization between 7 and 25 days, pleads for this pathogenic and minilally invasive concept of treatment. Key words: acute pancreatitis, therapeutic window, laparoscopic necrectomy

ACC/AHA/SCAI/AMA–Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association–Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance

Journal of the American College of Cardiology Ó 2014 by the American College of Cardiology Foundation, American Heart Association, Inc., American Medical Association, and National Committee for Quality Assurance Published by Elsevier Inc. Vol. 63, No. 7, 2014 ISSN 0735-1097/$36.00 http://dx.doi.org/10.1016/j.jacc.2013.12.003 PERFORMANCE MEASURES ACC/AHA/SCAI/AMA–Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association–Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance Developed in Collaboration With the American Association of Cardiovascular and Pulmonary Rehabilitation and Mended Hearts Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and Mended Hearts WRITING COMMITTEE MEMBERS Brahmajee K. Nallamothu, MD, MPH, FACC, FAHA, Co-Chair*; Carl L. Tommaso, MD, FACC, FAHA, FSCAI, Co-Chairy; H. Vernon Anderson, MD, FACC, FAHA, FSCAI*; Jeffrey L. Anderson, MD, FACC, FAHA, MACP*; Joseph C. Cleveland, J R , MDz; R. Adams Dudley, MD, MBA; Peter Louis Duffy, MD, MMM, FACC, FSCAIy; David P. Faxon, MD, FACC, FAHA*; Hitinder S. Gurm, MD, FACC; Lawrence A. Hamilton, Neil C. Jensen, MHA, MBA; Richard A. Josephson, MD, MS, FACC, FAHA, FAACVPRx; David J. Malenka, MD, FACC, FAHA*; Calin V. Maniu, MD, FACC, FAHA, FSCAIy; Kevin W. McCabe, MD; James D. Mortimer, Manesh R. Patel, MD, FACC*; Stephen D. Persell, MD, MPH; John S. Rumsfeld, MD, PhD, FACC, FAHAjj; Kendrick A. Shunk, MD, PhD, FACC, FAHA, FSCAI*; Sidney C. Smith, J R , MD, FACC, FAHA, FACP{; Stephen J. Stanko, MBA, BA, AA#; Brook Watts, MD, MS *ACC/AHA Representative. ySociety of Cardiovascular Angiography and Interventions Representative. zSociety of Thoracic Surgeons Representative. xAmerican Association of Cardiovascular and Pulmonary Rehabilitation Representative. kACC/AHA Task Force on Performance Measures Liaison. {National Heart Lung and Blood Institute Representative. #Mended Hearts Representative. The measure specifications were approved by the American College of Cardiology Board of Trustees, American Heart Association Science Advisory and Coordinating Committee, in January 2013 and the American Medical Association–Physician Consortium for Performance Improvement in February 2013. This document was approved by the American College of Cardiology Board of Trustees and the American Heart Association Science Advisory and Coordinating Committee in October 2013, and the Society of Cardiovascular Angiography and Interventions in December 2013. The American College of Cardiology requests that this document be cited as follows: Nallamothu BK, Tommaso CL, Anderson HV, Anderson JL, Cleveland JC, Dudley RA, Duffy PL, Faxon DP, Gurm HS, Hamilton LA, Jensen NC, Josephson RA, Malenka DJ, Maniu CV, McCabe KW, Mortimer JD, Patel MR, Persell SD, Rumsfeld JS, Shunk KA, Smith SC, Stanko SJ, Watts B. ACC/AHA/SCAI/AMA–Convened PCPI/NCQA 2013 perfor- mance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association–Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance. J Am Coll Cardiol 2014;63:722–45. This article has been copublished in Circulation. Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource.org) and the American Heart Asso- ciation (http://my.americanheart.org). For copies of this document, please contact Elsevier Inc. Reprint Department, fax (212) 633-3820, e-mail [email protected]. Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology. Requests may be completed online via the Elsevier site (http://www.elsevier.com/authors/obtaining- permission-to-re-use-elsevier-material). This Physician Performance Measurement Set (PPMS) and related data specifications were developed by the Physician Consortium for Performance Improvement (the Consortium), including the American College of Cardiology (ACC), the American Heart Association (AHA), and the American Medical Association (AMA), to facilitate quality-improvement activities by physicians. The performance measures contained in this PPMS are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications. Although copyrighted, they can be reproduced and distributed, without modification, for noncommercial purposesdfor example, use by health care pro

Making a Christian Private University Appealing to Prospective Students: The Case of Covenant University

Worldwide, universities are established to train highly skilled manpower that are expected to contribute to the development of their societies. Nigerian universities are expected to contribute to the achievement of the national goals using education as a tool. Before 1993, the provision of university education in Nigeria was a government monopoly. Many people could not be offered admissions into public universities because the existing facilities could not accommodate the deluge of requests. However, private universities have entered into the higher education service provision market. With many of them competing for prospective student enrolment, it is not surprising that some of them have deployed marketing strategies to attract students and make them stand out from the cluttered market. This paper examines how Covenant University, a Christian faith-based university and the acclaimed leader in the private university industry in the country has marketed itself. It found that it uses its product, people, work processes and serene physical location to attract new students. Importantly, it uses its relatively high tuition fees to position itself as the school for the children of the elites

Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization.

We describe a patient with interstitial granuloma annulare associated with subcutaneous injection therapy (SIT) for desensitization to a type I allergy. Asymptomatic, erythematous, violaceous annular patches were located at the injection sites on both her arms. Medical history revealed perennial rhinoconjonctivitis treated with SIT (Phostal Stallergen® cat 100% and D. pteronyssinus/D.farinae 50%:50%)